Roadblocks En Route to the Clinical Application of Induced Pluripotent Stem Cells

Overview

Journal J Cell Sci

Specialty Cell Biology

Date 2010 Feb 19

PMID 20164303

Citations 16

Authors

William E Lowry

William L Quan

Affiliations

Soon will be listed here.

Abstract

Since the first studies of human embryonic stem cells (hESCs) and, more recently, human induced pluripotent stem cells (hiPSCs), the stem-cell field has been abuzz with the promise that these pluripotent populations will one day be a powerful therapeutic tool. Although it has been proposed that hiPSCs will supersede hESCs with respect to their research and/or clinical potential because of the ease of their derivation and the ability to create immunologically matched iPSCs for each individual patient, recent evidence suggests that iPSCs in fact have several underappreciated characteristics that might mean they are less suitable for clinical application. Continuing research is revealing the similarities, differences and deficiencies of various pluripotent stem-cell populations, and suggests that many years will pass before the clinical utility of hESCs and hiPSCs is realized. There are a plethora of ethical, logistical and technical roadblocks on the route to the clinical application of pluripotent stem cells, particularly of iPSCs. In this Essay, we discuss what we believe are important issues that should be considered when attempting to bring hiPSC-based technology to the clinic.

Citing Articles

Non-viral, Tumor-free Induction of Transient Cell Reprogramming in Mouse Skeletal Muscle to Enhance Tissue Regeneration.

de Lazaro I, Yilmazer A, Nam Y, Qubisi S, Razak F, Degens H Mol Ther. 2018; 27(1):59-75.

PMID: 30470628 PMC: 6318817. DOI: 10.1016/j.ymthe.2018.10.014.

Frequency-induced morphology alterations in microconfined biological cells.

Banerjee H, Roy B, Chaudhury K, Srinivasan B, Chakraborty S, Ren H Med Biol Eng Comput. 2018; 57(4):819-835.

PMID: 30415434 DOI: 10.1007/s11517-018-1908-y.

Nanog induces suppression of senescence through downregulation of p27KIP1 expression.

Munst B, Thier M, Winnemoller D, Helfen M, Thummer R, Edenhofer F J Cell Sci. 2016; 129(5):912-20.

PMID: 26795560 PMC: 4813312. DOI: 10.1242/jcs.167932.

Current status of pluripotent stem cells: moving the first therapies to the clinic.

Kimbrel E, Lanza R Nat Rev Drug Discov. 2015; 14(10):681-92.

PMID: 26391880 DOI: 10.1038/nrd4738.

High-Throughput Assessment of Cellular Mechanical Properties.

Darling E, Di Carlo D Annu Rev Biomed Eng. 2015; 17:35-62.

PMID: 26194428 PMC: 8204286. DOI: 10.1146/annurev-bioeng-071114-040545.

References

Taura D, Noguchi M, Sone M, Hosoda K, Mori E, Okada Y . Adipogenic differentiation of human induced pluripotent stem cells: comparison with that of human embryonic stem cells. FEBS Lett. 2009; 583(6):1029-33. DOI: 10.1016/j.febslet.2009.02.031. View

Chin M, Mason M, Xie W, Volinia S, Singer M, Peterson C . Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell. 2009; 5(1):111-23. PMC: 3448781. DOI: 10.1016/j.stem.2009.06.008. View

Anderson L, Caldwell M . Human neural progenitor cell transplants into the subthalamic nucleus lead to functional recovery in a rat model of Parkinson's disease. Neurobiol Dis. 2007; 27(2):133-40. DOI: 10.1016/j.nbd.2007.03.015. View

Woltjen K, Michael I, Mohseni P, Desai R, Mileikovsky M, Hamalainen R . piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature. 2009; 458(7239):766-70. PMC: 3758996. DOI: 10.1038/nature07863. View

Kashiwagi H, Uchida K . Genome-wide profiling of gene amplification and deletion in cancer. Hum Cell. 2001; 13(3):135-41. View

Wernig M, Lengner C, Hanna J, Lodato M, Steine E, Foreman R . A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat Biotechnol. 2008; 26(8):916-24. PMC: 2654269. DOI: 10.1038/nbt1483. View

Ebert A, Yu J, Rose Jr F, Mattis V, Lorson C, Thomson J . Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature. 2008; 457(7227):277-80. PMC: 2659408. DOI: 10.1038/nature07677. View

Chamberlain S, Li X, Lalande M . Induced pluripotent stem (iPS) cells as in vitro models of human neurogenetic disorders. Neurogenetics. 2008; 9(4):227-35. DOI: 10.1007/s10048-008-0147-z. View

Kim J, Greber B, Arauzo-Bravo M, Meyer J, Park K, Zaehres H . Direct reprogramming of human neural stem cells by OCT4. Nature. 2009; 461(7264):649-3. DOI: 10.1038/nature08436. View

10.

Wheeler D, Srinivasan M, Egholm M, Shen Y, Chen L, McGuire A . The complete genome of an individual by massively parallel DNA sequencing. Nature. 2008; 452(7189):872-6. DOI: 10.1038/nature06884. View

11.

Karumbayaram S, Novitch B, Patterson M, Umbach J, Richter L, Lindgren A . Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells. 2009; 27(4):806-11. PMC: 2895909. DOI: 10.1002/stem.31. View

12.

Freund C, Mummery C . Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models. J Cell Biochem. 2009; 107(4):592-9. DOI: 10.1002/jcb.22164. View

13.

Ng S, Turner E, Robertson P, Flygare S, Bigham A, Lee C . Targeted capture and massively parallel sequencing of 12 human exomes. Nature. 2009; 461(7261):272-6. PMC: 2844771. DOI: 10.1038/nature08250. View

14.

Kim J, Sebastiano V, Wu G, Arauzo-Bravo M, Sasse P, Gentile L . Oct4-induced pluripotency in adult neural stem cells. Cell. 2009; 136(3):411-9. DOI: 10.1016/j.cell.2009.01.023. View

15.

Shi Y, Desponts C, Do J, Hahm H, Scholer H, Ding S . Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell. 2008; 3(5):568-74. DOI: 10.1016/j.stem.2008.10.004. View

16.

Park I, Zhao R, West J, Yabuuchi A, Huo H, Ince T . Reprogramming of human somatic cells to pluripotency with defined factors. Nature. 2007; 451(7175):141-6. DOI: 10.1038/nature06534. View

17.

Takahashi K, Yamanaka S . Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126(4):663-76. DOI: 10.1016/j.cell.2006.07.024. View

18.

Zhang D, Jiang W, Shi Y, Deng H . Generation of pancreatic islet cells from human embryonic stem cells. Sci China C Life Sci. 2009; 52(7):615-21. DOI: 10.1007/s11427-009-0095-3. View

19.

Thomson J, Itskovitz-Eldor J, Shapiro S, Waknitz M, Swiergiel J, Marshall V . Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282(5391):1145-7. DOI: 10.1126/science.282.5391.1145. View

20.

Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin I . Human induced pluripotent stem cells free of vector and transgene sequences. Science. 2009; 324(5928):797-801. PMC: 2758053. DOI: 10.1126/science.1172482. View